![Haverford Healthcare Advisors Announces the Completion of a Dermatopathology Practice Transaction](https://haverfordhealthcare.com/wp-content/uploads/2023/09/6481defe65f402615f7eea65_HHA-Company-Overview-Dermatopathology-Transactions-6-1-23-final-page-1-p-500.jpg)
We are pleased to announce that Haverford recently acted as the exclusive financial advisor to PRW Laboratories (“PRW”) in connection with a transaction with Versant Diagnostics effective May 1, 2023. PRW is a very successful dermatopathology lab that was founded in Charlottesville, Virginia in 2010. Please see Versant Diagnostics’ press release at https://bit.ly/3Nfijjw or visit their website at https://bit.ly/42qZIFq for additional details.
Over the years, Haverford has brokered the sale of numerous pathology practices and pathologist-owned clinical labs. PRW-Versant Diagnostics represents Haverford’s nineteenth completed dermatopathology lab transaction, in addition to dozens of other pathology practice and clinical laboratory transactions on which we have also advised.
![](https://haverfordhealthcare.com/wp-content/uploads/2023/09/648cb0b7c81a9f4652abff7c_HHA-Company-Overview-Dermatopathology-Transactions-6-1-23-final-dragged.png)